Billets de Michelle Dawson

Billet publié sur Twitter/X le 04/10/2021 15:21

Twitter/X Publication avec DOI crossref Extrait cité dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Thomson Patrick Joseph, Fang Zhou, Liu Yang Sai, Hanyu Chen, Stanley Li Lin, Melitta Schachner (2022). Duloxetine ameliorates valproic acid‐induced hyperactivity, anxiety‐like behavior, and social interaction deficits in zebrafish. Autism Research, 15(1), 27-41. Wiley.

Date de publication
03/10/2021
Identifiant
10.1002/aur.2620
Auteurs
Thomson Patrick Joseph, Fang Zhou, Liu Yang Sai, Hanyu Chen, Stanley Li Lin, Melitta Schachner
Source
Autism Research
Détails
15(1), 27-41
Type de référence
article
Éditeur
Wiley
Source de métadonnées
crossref

Résumé

Abstract Syndromic autism spectrum disorders (ASDs) are characterized by impaired social communication and repetitive/stereotyped behaviors. Currently available therapeutic agents against ASD have limited efficacy. Thus, searching for novel and effective drugs ameliorating core symptoms, in particular social deficits, is of utmost importance. Duloxetine (DLX), an antidepressant that has been identified as an agonist mimetic for the cell adhesion molecule L1, exhibits beneficial functions in vitro and in vivo. Therefore, in this study, we focused on the rapid and persistent neuroprotective function of DLX following valproic acid (VPA)‐triggered hyperactivity, anxiety‐like behavior and social deficits in zebrafish. Embryonic exposure to VPA reduced survival in a dose‐ and time‐dependent manner, delayed hatching, and also resulted in a significant number of malformed larvae. After initial dose–response experiments in zebrafish larvae, 10 μM VPA exposure between 0.33 and 4.5 days post fertilization (dpf) was identified as an effective concentration that led to an early and persistent ASD‐like phenotype in zebrafish. ASD‐like elevated acetylcholine esterase (AChE) activity and reduced Akt–mTOR signaling was observed in zebrafish whole brain. Acute administration of DLX (4.5–6 dpf) reduced the VPA‐induced ASD‐like phenotype in zebrafish larvae. Additionally, such early‐life acute DLX treatment had long‐term effects in ameliorating social impairments, hyperactivity, and anxiety‐like behaviors through adulthood. This was accompanied by reduced AChE activity and by normalized Akt–mTOR signaling. Overall, DLX treatment showed a long‐term therapeutic effect on autistic‐like behaviors, and alteration of AChE activity and Akt–mTOR signaling were identified as crucial in the VPA‐induced ASD zebrafish model.

Auteur·ices de l’étude dans cette référence citée